These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1459179)

  • 1. Colchicine analogues: effect on amyloidogenesis in a murine model and, in vitro, on polymorphonuclear leukocytes.
    Wolach B; Gotfried M; Jedeikin A; Lishner M; Brossi A; Ravid M
    Eur J Clin Invest; 1992 Sep; 22(9):630-4. PubMed ID: 1459179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of colchicine. II. Effects of colchicine and its analogs on phagocytosis and chemotaxis in vitro.
    Chang YH
    J Pharmacol Exp Ther; 1975 Jul; 194(1):159-64. PubMed ID: 1151747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the second phase of amyloidogenesis in a mouse model by a single-dose colchicine regimen.
    Shtrasburg S; Pras M; Gal R; Salai M; Livneh A
    J Lab Clin Med; 2001 Aug; 138(2):107-11. PubMed ID: 11477377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of a targeted and more potent, anti-Inflammatory derivative of colchicine: Implications for gout.
    Paré G; Vitry J; Marceau F; Vaillancourt M; Winter P; Bachelard H; Naccache PH; Tuszynski JA; Fernandes MJ
    Biochem Pharmacol; 2020 Oct; 180():114125. PubMed ID: 32598947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of colchicine derivatives on lysosomal enzyme release from polymorphonuclear leukocytes and intracellular levels of cAMP after phagocytosis of monosodium urate crystals.
    Mikulíkova D; Trnavský K
    Biochem Pharmacol; 1980 Aug; 29(15):2146-8. PubMed ID: 6250550
    [No Abstract]   [Full Text] [Related]  

  • 6. Colchicine inhibition of the first phase of amyloid synthesis in experimental animals.
    Keizman IK; Greenwald M; Ravid M
    Br J Exp Pathol; 1976 Dec; 57(6):686-8. PubMed ID: 1008998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphonuclear leukocyte motility in vitro. IV. Colchicine inhibition of chemotactic activity formation after phagocytosis of urate crystals.
    Phelps P
    Arthritis Rheum; 1970; 13(1):1-9. PubMed ID: 5439313
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of colchicine on the periodicity of the spontaneous and induced respiratory burst of granulocytes and monocytes during familial Mediterranean fever].
    Akopian VP; Avetisian SA; Davtian TK
    Eksp Klin Farmakol; 2005; 68(6):36-9. PubMed ID: 16405032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A proposed model for chemotactic deactivation: evidence for microtubule modulation of polymorphonuclear leukocyte chemotaxis.
    Spilberg I; Mandell B; Hoffstein S
    J Lab Clin Med; 1979 Aug; 94(2):361-9. PubMed ID: 458252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colchicine (problems of its pharmacokinetics, mechanism of action and use in therapeutic practice)].
    Kochubeĭ LN; Tatevosian KG
    Revmatologiia (Mosk); 1985; (2):61-4. PubMed ID: 3901198
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-amyloid drugs: potential in the treatment of diseases associated with aging.
    Kisilevsky R
    Drugs Aging; 1996 Feb; 8(2):75-83. PubMed ID: 8845588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of polymorphonuclear leucocytes and T lymphocytes in experimental murine amyloidosis.
    Kedar I; Ravid M
    Eur J Clin Invest; 1980 Feb; 10(1):63-5. PubMed ID: 6768570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphonuclear leukocyte motility in vitro: IV. Colchicine inhibition of chemotactic activity formation after phagocytosis of urate crystals.
    Phelps P
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S25-33. PubMed ID: 18240263
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and Antiproliferative Screening Of Novel Analogs of Regioselectively Demethylated Colchicine and Thiocolchicine.
    Czerwonka D; Sobczak S; Maj E; Wietrzyk J; Katrusiak A; Huczyński A
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32151042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of DNCB-induced irritant dermatitis by colchicine.
    Miyachi Y; Takigawa M; Imamura S
    Acta Derm Venereol; 1981; 61(4):307-11. PubMed ID: 6173985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the lack of the P-glycoprotein efflux pump in neutrophils explain the efficacy of colchicine in familial Mediterranean fever and other inflammatory diseases?
    Ben-Chetrit E; Levy M
    Med Hypotheses; 1998 Nov; 51(5):377-80. PubMed ID: 9848464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential anticancer role of colchicine-based derivatives: an overview.
    Kumar A; Sharma PR; Mondhe DM
    Anticancer Drugs; 2017 Mar; 28(3):250-262. PubMed ID: 28030380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human polymorphonuclear leukocytes: demonstration of microtubules and effect of colchicine.
    Malawista SE; Bensch KG
    Science; 1967 Apr; 156(3774):521-2. PubMed ID: 6021678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of colchicine. V. Neutrophil adherence and phagocytosis in patients with acute gout treated with colchicine.
    Dallaverde E; Fan PT; Chang YH
    J Pharmacol Exp Ther; 1982 Oct; 223(1):197-202. PubMed ID: 7120118
    [No Abstract]   [Full Text] [Related]  

  • 20. Colchicine modulates expression of pro-inflammatory genes in neutrophils from patients with familial Mediterranean fever and healthy subjects.
    Manukyan G; Petrek M; Tomankova T; Martirosyan A; Tatyan M; Navratilova Z; Paulu D; Kriegova E
    J Biol Regul Homeost Agents; 2013; 27(2):329-36. PubMed ID: 23830384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.